Track record · closed signal

Gilead Sciences Inc (GILD) — closed signal from March 16, 2026

Partial Published before the outcome was known, scored automatically when the window closed on June 14, 2026.

Predicted vs. what happened

GILD price · publication thesis → realized outcomesplit-adjusted
$145.09 Published $158.55 Target $124.77 Window close $145.75 Peak
$141.14 – $145.09Entry zone — fair-value band
$145.09Published — price the day we called it
$158.55Target — the price the thesis aimed for
$145.75Peak — highest point inside the window, not a realized return
$124.77Window close — end-of-window price, context only

What happened

Partial

Reached 5% of the predicted growth at its peak, without hitting the target.

Peak price
$145.75
peak on March 17, 2026 — not a realized return
Peak gain
+0.5%
peak, from the publication price
Window close
$124.77
end-of-window price, context only
Days to target
—
Window
March 16, 2026 – June 14, 2026

The thesis — published March 16, 2026

Predicted growth
+10%
over the measurement window
Target price
$158.55
the price the thesis aimed for
Entry zone
$141.14 – $145.09
the fair-value band we waited for
Price at publication
$145.09
published March 16, 2026
Confidence
71%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Gilead is a steadier healthcare pick after some analysts upgraded it and a deal with Arcellx raised hopes about its drug pipeline. Its HIV business brings reliable cash, so the stock looks safer than many biotech names. It likely won't jump dramatically, but for the next 0-3 months, a Watch makes sense because of its defensive cash flow and calmer price action.

Primary drivers

  • Steady cash from HIV treatments helps stabilize the company
  • Analyst upgrades improved how investors view the stock
  • The Arcellx deal increases possible future drug opportunities
  • Buying near the entry zone fits a lower-volatility healthcare trade

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All GILD signals